^○Tohru Kitada¹, Ardah Mustafa², Haque Emdadul² (1.Otawa-Kagaku,Neuroscience, Japan, 2.United Arab Emirates University, College of Medicine and Health Sciences, Department of Biochemistry and Molecular Biology)

^○Rie Tohge¹, Satoshi Kaneko¹, Norihiro Takenouchi², Yusuke Yakushiji¹ (1.Department of Neurology, Kansa Medical University, Japan, 2.Department of Microbiology, Kansai Medical University)

^○Masanori Sawamura, Rie Hikawa, Junichiro Ohira, Hodaka Yamakado, Ryosuke Takahashi (Department of Neurology, Kyoto University Hospital, Japan)

^○Masaya Imoto, Tetsushi Kataura, Yukiko Sasazawa, Shinji Saiki, Nobutaka Hattori (Department of Neurology, Juntendo University School of Medicine, Japan)

^○Kahori Fukushima¹, Tsuyoshi Inoshita², Jun Ogata³, Yuzuru Imai^4,5, Nobutaka Hattori^1,2,4,5 (1.Department of drug development for Parkinson's disease, Juntendo University Graduate School of Medicine, Japan, 2.Department of Neurodegenerative and Demented Disorders, Juntendo University Graduate School of Medicine., 3.Juntendo Advanced Research Institute for Health Science, Juntendo University Graduate School of Medicine, 4.Department of Research for Parkinson's Disease, Juntendo University, 5.Department of Neurology, Juntendo University School of Medicine.)

^○Yoshitsugu Nakamura, Shigeki Arawaka (Osaka Medical and Pharmaceutical University, Japan)